Long-serving Sask. NDP MLA steps down in hopes of federal Liberal run
Longtime NDP MLA Buckley Belanger has announced he is resigning his seat in hopes of running for the federal Liberals in the next election.
The Athabasca MLA's move comes as the prospect of a writ drop seems increasingly likely.
"Our communities are facing long-standing challenges that were exacerbated by the pandemic. That is why we need a strong voice advocating for our region in Ottawa as we look to rebuild and recover,” Belanger said in a news release.
Belanger has served in the Saskatchewan legislature for more than 26 years. He was first elected in 1995.
During that time he served both in government — under NDP premiers Roy Romanow and Lorne Calvert — and in opposition following the Saskatchewan Party's rise to power in 2007.
"We're sorry to see Mr. Belanger leave our caucus and are grateful for his service as Saskatchewan's longest-serving Indigenous MLA. Our focus now will be making sure there is a strong voice for northwest Saskatchewan in the legislature," NDP Leader Ryan Meili said in a statement.
Belanger is seeking the Liberal nomination for the northern Saskatchewan riding of Desnethe-Missinippi-Churchill River.
If successful, Belanger will challenge Conservative Gary Vidal in the northern Saskatchewan riding of Desnethe-Missinippi-Churchill River.
The first-term MP won the seat in 2019 in a three-way battle between incumbent NDP candidate Georgina Jolibois and Liberal challenger, Lac La Ronge Indian Band Chief Tammy Cook-Searson.
Belanger 's resignation will be effective Aug. 15, the news release said.
Do you have a story idea or news tip? Email us!
CTVNews.ca Top Stories
Heat warnings to last into the weekend for some provinces
A heat wave is expected to hit parts of Ontario, Quebec and New Brunswick this week, and it could feel as warm as 45, according to latest forecasts.
opinion Symbolic meaning behind Princess of Wales' style choices at first public appearance since diagnosis revealed
The Trooping the Colour marked the first public outing this year for the Princess of Wales, who has not been seen at any official royal engagements since December 2023. We now know that was due to abdominal surgery and preventive chemotherapy, with no return to public life anytime soon. But the Princess of Wales chose this occasion to soft launch her return to royal life, and it was eagerly anticipated.
'People get very sick': Manitoba sees rise in rare, potentially fatal bacterial infection
A rise in cases of a rare bacterial infection in Manitoba has prompted health officials to issue a warning.
Calgary mayor says 3 to 5-week repair timeline is the 'maximum'
Calgary Mayor Jyoti Gondek says work is progressing simultaneously on five issues identified in the city's feeder main last week and residents are being asked for continued patience with water conservation measures.
CMHC says annual pace of housing starts in May up 10 per cent from April
Canada Mortgage and Housing Corp. says the annual pace of housing starts in May climbed 10 per cent compared with April, helped by gains in Montreal and Toronto.
2 Canadian cities ranked high on global list of most expensive places to buy a home
As Canadians continue to struggle with the extremely high cost of buying a home in some of the country’s major urban centres, a new global report is underscoring just how expensive some of those markets are.
Scientists may have found an answer to the mystery of dark matter. It involves an unexpected byproduct
For about 50 years, the scientific community has been grappling with a substantial problem: There isn’t enough visible matter in the universe.
Nuclear-armed nations are deepening their reliance on their nuclear weapons, watchdog finds
The world's nine nuclear-armed states continue to modernize their nuclear weapons as the countries deepened their reliance on such deterrence in 2023, a Swedish think tank said Monday.
World's first weekly insulin injection coming to Canada in 2 weeks, manufacturer says
Many people with diabetes in Canada will soon be able to take insulin once a week instead of daily, drug manufacturer Novo Nordisk announced on Monday.